As the largest independent funder of MND/ALS research in Australia, FightMND’s vision is a world without MND. Integral in this vision is our determination to help facilitate the translation of the growing body of new knowledge about the disease into a cure for MND/ALS patients internationally. FightMND offers funding opportunities for both national and international researchers through a number of research schemes. Grant criteria and conditions are detailed below.

RESEARCH GRANT CRITERIA

Researchers working in areas relevant to improving the translation of/or progressing the development of potential therapies for Motor Neurone Disease (MND) are invited to apply for funding to support research projects commencing in 2020.

We are pleased to announce a call for the following FightMND Research Grants.

Clinical Trial Grants

These grants support Phase II/III clinical trials of novel, high-potential treatments for MND/ALS within the Australian Clinical Trials Consortium.

Click here to download a copy of the Clinical Trial Grants Criteria

Click here to download the Clinical Trial Grants Coversheet

These grants are awarded with an offer of up to AUD $1,500,000 (Phase II/III trial) with a project performance of up to 3 years.

Eligibility: Applications are open to MND/ALS researchers globally. Australian trial sites mandatory.

 KEY DATES

  • Applications Open:November 1st 2019
  • Letter of Intent due:January 17th 2020
  • Submit Letter of Intent to: [email protected]g.au
  • Invitation to submit full application:February 3rd 2020
  • Full application due:5:30pm AEDT April 1st 2020
  • Recipients Notified: July 2020

Drug Development Grants

These grants support the preclinical research, development and assessment of therapeutics for MND/ALS through to (and including) completion of Phase I clinical trials.

Click here to download a copy of the Drug Development Grants Criteria

Click here to download the Drug Development Grants Coversheet

These grants are each awarded with an offer of up to AUD $1,000,000 in support available for 3-year projects (Projects with a period of performance of less than 3-years will also be considered).

Eligibility: Applications are open to MND/ALS researchers globally.

KEY DATES

  • Applications Open:November 1st 2019
  • Letter of Intent due:January 17th 2020
  • Submit Letter of Intent to: [email protected]
  • Invitation to submit full application:February 3rd 2020
  • Full application due:5:30pm AEDT April 1st 2020
  • Recipients Notified: July 2020

IMPACT Grants

IMPACT (IMProving and ACcelerating Translation) Grants support projects focused on one or more of the following key issues contributing to the lack of translation of effective treatments through to clinical trial for MND/ALS:

  1. Disease heterogeneity
  2. Lack of relevant preclinical models
  3. A lack of reliable disease biomarkers
  4. The challenge of drug delivery into the brain
  5. A lack of effective targeted gene therapies
  6. The untapped potential of stem cell therapy

Click here to download a copy of the IMPACT Grant Criteria

Click here to download the IMPACT Grants Coversheet

These grants are for support of 2-year projects up to the value of AUD $250,000. Proposals for both discovery and translational research stages will be considered.

Eligibility: Applications are invited for research based in institutions within Australia. Investigators at all academic levels are eligible to submit applications.

Please note that applicants are limited to one (1) CIA and two (2) Co-CI applications for this grant scheme.

KEY DATES

  • Applications Open:November 1st 2019
  • Full application due:5:30pm AEDT April 1st 2020
  • Recipients Notified: July 2020

Please see individual grant application guidelines for further information or for further enquiries, please contact Dr Davor Stanic, FightMND Research Coordinator, [email protected]